id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0356-0016,FDA,FDA-1977-N-0356,"Drugs for Human Use; Drug Efficacy Study Implementation; Nitroglycerin
Transdermal Systems; Withdrawal of Hearing Request; Withdrawal of
Applications; Final Resolution of Hearing Requests Regarding
Transdermal Systems Under Docket",Notice,Announcement,2015-11-16T05:00:00Z,2015,11,2015-11-16T05:00:00Z,,2024-11-07T23:35:36Z,2015-28853,1,0,0900006481d488ba
FDA-1977-N-0356-0015,FDA,FDA-1977-N-0356,Letter from FDA CDER to Sandoz Inc.,Other,Letter(s),2015-10-22T04:00:00Z,2015,10,2015-10-22T04:00:00Z,,2015-10-22T18:51:06Z,,0,0,0900006481ce26c2
FDA-1977-N-0356-0012,FDA,FDA-1977-N-0356,Correspondence from Zuckerman Spaeder LLP to FDA CDER,Other,Correspondence,2015-04-09T04:00:00Z,2015,4,2015-04-09T04:00:00Z,,2015-04-09T17:09:18Z,,0,0,09000064810080e6
FDA-1977-N-0356-0013,FDA,FDA-1977-N-0356,Request for Hearing from Lumara Health Inc,Other,Request for Hearing,2015-04-09T04:00:00Z,2015,4,2015-04-09T04:00:00Z,,2015-05-13T14:52:12Z,,0,0,0900006481a98273
FDA-1977-N-0356-0014,FDA,FDA-1977-N-0356,Withdrawal of Hearing Request from Lumara Health Inc,Other,Withdrawal,2015-04-09T04:00:00Z,2015,4,2015-04-09T04:00:00Z,,2015-05-13T14:51:10Z,,0,0,0900006481a98274